Status:
COMPLETED
Study of the Use of Coated Venous Catheters in the Critically Ill Child
Lead Sponsor:
Corewell Health West
Collaborating Sponsors:
Helen DeVos Children's Hospital
Conditions:
Children in the Pediatric Intensive Care Unit or General Pediatric Care Unit Requiring a Central Venous Catheter
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE4
Brief Summary
This study should help determine to determine whether or not the use of an antibiotic coated catheter will significantly reduce the number of central line related bloodstream infections in children re...
Detailed Description
Catheter related infections are often difficult to treat because the pathogen may form a biofilm that actually embeds itself into the catheter material. Additionally, the catheter hub and skin around ...
Eligibility Criteria
Inclusion
- all patients ages 21 years or less admitted to the pediatric intensive care unit or general pediatric unit at DeVos Children's Hospital
- research informed consent must be signed
Exclusion
- known allergy or sensitivity to minocycline, tetracyline, doxycycline, oxytetracycline, demeclocycline, rifampin, rifabutin
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
End Date :
October 1 2005
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00202813
Start Date
July 1 2003
End Date
October 1 2005
Last Update
April 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DeVos Children's Hospital
Grand Rapids, Michigan, United States, 49503